Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Italy / NCT06800807
Recruiting Observational

Metacognitive Beliefs in Adolescents With Eating and Nutrition Disorders

NCT06800807 · tracked via the Priya Life Science Italy tracker
Sponsor
Istituto Auxologico Italiano
Phase
Observational
Started
2024-06-26
Last updated
2026-03-30

Condition(s) studied

Feeding and Eating Disorders

Investigational drug(s) / intervention(s)

Observation of several factors involved in eating and nutrition disorders

Observation of several factors involved in eating and nutrition disorders: Observation of symptomatology of eating and nutrition disorders, metacognitive beliefs, brooding and rumination.

Study summary

The present study aims to study the presence of metacognitive beliefs in adolescent subjects with eating and nutrition disorders (END) compared with a control group composed of subjects of the same sex and age belonging to the general population.

Eligibility

Sex
FEMALE
Min age
12 Years
Max age
17 Years
Healthy volunteers
No
Eating and nutrition disorders (END) Inclusion Criteria: * Female sex * Age: 12 to 17 years * Italian nationality * Diagnosis relating to the END framework according to the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Exclusion Criteria: * Absence of signed Informed Consent Control group Inclusion Criteria: * Female sex * Age: 12 to 17 years * Italian nationality Exclusion Criteria: * Absence of signed Informed Consent

Primary outcome measure(s)

  • Metacognitive beliefs — Baseline
    Metacognition Questionnaire (MCQ-30; Cartwright-Hatton \& Wells, 1997), a self-report test composed of 30 items on a 4-point Likert scale from 1 (I do not agree) to 4 (I completely agree 'agreement)
  • Brooding — Baseline
    Penn State Worry Questionnaire (PSWQ; Meyer et at., 1990), a self-report test composed of 16 items on a 5-point Likert scale from 1 (not at all typical) to 5 (very typical)
  • Rumination — Baseline
    Ruminative Response Scale (RRS; Nolen-Hoeksema and Morrow, 1991), a self-report test composed of 20 items on a 4-point Likert scale from 1 (almost never) to 4 (almost always)

Trial sites (1)

FacilityCityRegionStatus
Istituto Auxologico Italiano IRCCS, Site Piancavallo Oggebbio Verbania Recruiting

More Istituto Auxologico Italiano trials in Italy

Implantable Loop Recorder and Cardioneuroblation Starting soon
Vesiculogenesis in Children With GH Deficiency (VESCIGHTP) Active, not recruiting
Exploring the Full Body Representation in Anorexia Nervosa and Bulimia Nervosa Recruiting
Impact of WBC on Patients With Metabolic or Neurological Diseases or Fibromyalgia (WBC-MeNeFi) Recruiting
The FUnctional TricUspid REgurgitation by 3D EChocardiography Cooperative Study Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06800807 on ClinicalTrials.gov ↗ ← All trials in Italy